Plasma Protein Therapeutics Global Market Report 2025

Description

Plasma protein therapeutics involves treatments derived from plasma and their recombinant counterparts, designed to address specific medical conditions by replacing deficient or missing proteins present in plasma. This enables recipients to lead healthier and more productive lives.

The primary products within plasma protein therapeutics include immunoglobulin, albumin, coagulation factor, c1-esterase inhibitors, and other related products. Immunoglobulin constitutes a component of blood plasma containing antibodies, and it is administered through various routes such as intravenous and subcutaneous. These treatments find applications in addressing conditions such as primary immunodeficiency disorder (PID), idiopathic thrombocytopenic purpura, secondary immunodeficiency, hereditary angioedema, and various other medical needs.

The plasma protein therapeutics market research report is one of a series of new reports from The Business Research Company that provides plasma protein therapeutics market statistics, including plasma protein therapeutics industry global market size, regional shares, competitors with a plasma protein therapeutics market share, detailed plasma protein therapeutics market segments, market trends, and opportunities, and any further data you may need to thrive in the plasma protein therapeutics industry. This plasma protein therapeutics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The plasma protein therapeutics market size has grown strongly in recent years. It will grow from $31.86 billion in 2024 to $34.55 billion in 2025 at a compound annual growth rate (CAGR) of 8.5%. The growth in the historic period can be attributed to increasing prevalence of rare diseases, growing aging population, global blood plasma supply, rise in hemophilia cases, improvements in diagnosis, supportive regulatory environment.

The plasma protein therapeutics market size is expected to see strong growth in the next few years. It will grow to $46.35 billion in 2029 at a compound annual growth rate (CAGR) of 7.6%. The growth in the forecast period can be attributed to gene therapy advancements, increasing healthcare expenditure, expanded indications, precision medicine approaches, patient access programs. Major trends in the forecast period include technological innovations, telemedicine adoption, technological advancements in plasma fractionation, development of next-generation therapies, adoption of recombinant therapies, personalized medicine approaches.

The rising prevalence of autoimmune disorders is anticipated to drive the growth of the plasma protein therapeutics market in the future. Autoimmune disorders occur when the body's immune system mistakenly attacks and destroys healthy cells. Therapeutic plasma exchange is a treatment used for these diseases, wherein the body incorrectly identifies part of itself as foreign and produces proteins called autoantibodies that target these misidentified areas. For instance, in May 2023, a study conducted by the University of Glasgow, a public university in the UK, involving 22 million people, revealed that autoimmune disorders affect approximately 10% of the UK population, surpassing previous estimates. Thus, the increasing incidence of autoimmune disorders is propelling the growth of the plasma protein therapeutics market moving forward.

The growth of the plasma protein therapeutics market is expected to be propelled by the increasing prevalence of chronic diseases. Chronic diseases, lasting a year or longer and requiring ongoing medical care, significantly impact daily activities. Plasma protein therapeutics play a crucial role in managing chronic diseases by addressing deficiencies, modulating the immune system, and providing support for various physiological functions. According to the World Health Organization's data from September 2022, non-communicable diseases (NCDs) or chronic diseases account for 74% of the 41 million deaths globally each year. Cardiovascular diseases, cancer, chronic respiratory diseases, and diabetes contribute significantly to this statistic. Therefore, the growing prevalence of chronic diseases is driving the growth of the plasma protein therapeutics market.

Product innovations are emerging as a significant trend in the plasma protein therapeutics market. Major companies in this sector are concentrating on developing innovative products to secure a competitive edge. For example, in October 2023, Octapharma AG, a Switzerland-based company, received approval from European medical authorities for the lyophilized version of its well-known product, octaplasLG. This advanced formulation is intended for pre-hospital transfusions, offering healthcare professionals a convenient and effective option for managing patients in critical conditions. This approval highlights Octapharma's dedication to improving patient care through innovative solutions in the blood products arena.

Strategic collaborations are playing a crucial role in the plasma protein therapeutics market. Major companies are entering partnerships to enhance their product portfolios, extend global reach, and drive innovation in new therapy development. For instance, LFB Plasma, a US-based plasma collection company, announced a collaboration with the Plasma Protein Therapeutics Association (PPTA) in September 2022. This strategic partnership is aimed at expanding LFB Plasma's presence in the US and reinforcing its commitment to both plasma donors and patients.

In April 2022, Grifols S.A., a Spain-based pharmaceutical and chemical manufacturer, acquired Tiancheng (Germany) Pharmaceutical Holdings AG for €1.6 billion ($1.72 billion). This acquisition is expected to accelerate and broaden Grifols' product portfolio, increase patient access to plasma therapies, and drive revenue growth and margin expansion. Tiancheng (Germany) Pharmaceutical Holdings AG, also known as Biotest, is a Germany-based healthcare company specializing in innovative hematology and clinical immunology, focusing on the development, manufacturing, and marketing of plasma proteins and biotherapeutic drugs.

Major companies operating in the plasma protein therapeutics market include CSL Behring LLC, Grifols SA, China Biologic Products Holdings Inc., Takeda Pharmaceutical Company Limited, Baxter International Inc., Kedrion SpA, LFB SA, Emergent BioSolutions Inc., Reliance Life Sciences Private Limited, ADMA Biologics Inc., Prothya Biosolutions BV, Bio Products Laboratory Ltd., Biotest AG, Taibang Biological Group Co Ltd, Octapharma Plasma Inc., New York Blood Center, Green Cross Corporation, China National Biotec Group Company Limited, Kamada Ltd., Australian Red Cross Lifeblood

North America was the largest region in the plasma protein therapeutics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the plasma protein therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the plasma protein therapeutics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The plasma protein therapeutics market includes revenues earned by entities by providing therapy for liver disease and bleeding from trauma by using Alpha-1 Proteinase Inhibitors, Hyperimmune Globulins. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Plasma Protein Therapeutics Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on plasma protein therapeutics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for plasma protein therapeutics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The plasma protein therapeutics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Product: Immunoglobulin; Albumin; Coagulation Factor; C1-esterase Inhibitors; Other Products
2) By Route Of Administration: Intravenous; Subcutaneous
3) By Applications: Primary Immunodeficiency Disorder (PID); Idiopathic Thrombocytopenic Purpura; Secondary Immunodeficiency; Hereditary Angioedema; Other Applications
Subsegments:
1) By Immunoglobulin: Intravenous Immunoglobulin (IVIG); Subcutaneous Immunoglobulin (SCIG)
2) By Albumin: Human Serum Albumin; Recombinant Albumin
3) By Coagulation Factor: Factor VIII; Factor IX; Prothrombin Complex Concentrates
4) By C1-Esterase Inhibitors: Human C1-Esterase Inhibitors; Recombinant C1-Esterase Inhibitors
5) By Other Products: Fibrinogen; Alpha-1 Antitrypsin; Clotting Factor Concentrates
Companies Mentioned: CSL Behring LLC; Grifols SA; China Biologic Products Holdings Inc.; Takeda Pharmaceutical Company Limited; Baxter International Inc.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

Product Code: r23650

1. Executive Summary

2. Plasma Protein Therapeutics Market Characteristics

3. Plasma Protein Therapeutics Market Trends And Strategies

4. Plasma Protein Therapeutics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Plasma Protein Therapeutics Growth Analysis And Strategic Analysis Framework

5.1. Global Plasma Protein Therapeutics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Plasma Protein Therapeutics Market Growth Rate Analysis
5.4. Global Plasma Protein Therapeutics Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Plasma Protein Therapeutics Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Plasma Protein Therapeutics Total Addressable Market (TAM)

6. Plasma Protein Therapeutics Market Segmentation

6.1. Global Plasma Protein Therapeutics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Immunoglobulin
Albumin
Coagulation Factor
C1-esterase Inhibitors
Other Products
6.2. Global Plasma Protein Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Intravenous
Subcutaneous
6.3. Global Plasma Protein Therapeutics Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Primary Immunodeficiency Disorder (PID)
Idiopathic Thrombocytopenic Purpura
Secondary Immunodeficiency
Hereditary Angioedema
Other Applications
6.4. Global Plasma Protein Therapeutics Market, Sub-Segmentation Of Immunoglobulin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Intravenous Immunoglobulin (IVIG)
Subcutaneous Immunoglobulin (SCIG)
6.5. Global Plasma Protein Therapeutics Market, Sub-Segmentation Of Albumin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Human Serum Albumin
Recombinant Albumin
6.6. Global Plasma Protein Therapeutics Market, Sub-Segmentation Of Coagulation Factor, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Factor VIII
Factor IX
Prothrombin Complex Concentrates
6.7. Global Plasma Protein Therapeutics Market, Sub-Segmentation Of C1-Esterase Inhibitors, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Human C1-Esterase Inhibitors
Recombinant C1-Esterase Inhibitors
6.8. Global Plasma Protein Therapeutics Market, Sub-Segmentation Of Other Products, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Fibrinogen
Alpha-1 Antitrypsin
Clotting Factor Concentrates

7. Plasma Protein Therapeutics Market Regional And Country Analysis

7.1. Global Plasma Protein Therapeutics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Plasma Protein Therapeutics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Plasma Protein Therapeutics Market

8.1. Asia-Pacific Plasma Protein Therapeutics Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Plasma Protein Therapeutics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Plasma Protein Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Plasma Protein Therapeutics Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Plasma Protein Therapeutics Market

9.1. China Plasma Protein Therapeutics Market Overview
9.2. China Plasma Protein Therapeutics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Plasma Protein Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Plasma Protein Therapeutics Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Plasma Protein Therapeutics Market

10.1. India Plasma Protein Therapeutics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Plasma Protein Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Plasma Protein Therapeutics Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Plasma Protein Therapeutics Market

11.1. Japan Plasma Protein Therapeutics Market Overview
11.2. Japan Plasma Protein Therapeutics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Plasma Protein Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Plasma Protein Therapeutics Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Plasma Protein Therapeutics Market

12.1. Australia Plasma Protein Therapeutics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Plasma Protein Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Plasma Protein Therapeutics Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Plasma Protein Therapeutics Market

13.1. Indonesia Plasma Protein Therapeutics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Plasma Protein Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Plasma Protein Therapeutics Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Plasma Protein Therapeutics Market

14.1. South Korea Plasma Protein Therapeutics Market Overview
14.2. South Korea Plasma Protein Therapeutics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Plasma Protein Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Plasma Protein Therapeutics Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Plasma Protein Therapeutics Market

15.1. Western Europe Plasma Protein Therapeutics Market Overview
15.2. Western Europe Plasma Protein Therapeutics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Plasma Protein Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Plasma Protein Therapeutics Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Plasma Protein Therapeutics Market

16.1. UK Plasma Protein Therapeutics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Plasma Protein Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Plasma Protein Therapeutics Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Plasma Protein Therapeutics Market

17.1. Germany Plasma Protein Therapeutics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Plasma Protein Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Plasma Protein Therapeutics Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Plasma Protein Therapeutics Market

18.1. France Plasma Protein Therapeutics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Plasma Protein Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Plasma Protein Therapeutics Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Plasma Protein Therapeutics Market

19.1. Italy Plasma Protein Therapeutics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Plasma Protein Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Plasma Protein Therapeutics Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Plasma Protein Therapeutics Market

20.1. Spain Plasma Protein Therapeutics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Plasma Protein Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Plasma Protein Therapeutics Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Plasma Protein Therapeutics Market

21.1. Eastern Europe Plasma Protein Therapeutics Market Overview
21.2. Eastern Europe Plasma Protein Therapeutics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Plasma Protein Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Plasma Protein Therapeutics Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Plasma Protein Therapeutics Market

22.1. Russia Plasma Protein Therapeutics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Plasma Protein Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Plasma Protein Therapeutics Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Plasma Protein Therapeutics Market

23.1. North America Plasma Protein Therapeutics Market Overview
23.2. North America Plasma Protein Therapeutics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Plasma Protein Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Plasma Protein Therapeutics Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Plasma Protein Therapeutics Market

24.1. USA Plasma Protein Therapeutics Market Overview
24.2. USA Plasma Protein Therapeutics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Plasma Protein Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Plasma Protein Therapeutics Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Plasma Protein Therapeutics Market

25.1. Canada Plasma Protein Therapeutics Market Overview
25.2. Canada Plasma Protein Therapeutics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Plasma Protein Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Plasma Protein Therapeutics Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Plasma Protein Therapeutics Market

26.1. South America Plasma Protein Therapeutics Market Overview
26.2. South America Plasma Protein Therapeutics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Plasma Protein Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Plasma Protein Therapeutics Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Plasma Protein Therapeutics Market

27.1. Brazil Plasma Protein Therapeutics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Plasma Protein Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Plasma Protein Therapeutics Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Plasma Protein Therapeutics Market

28.1. Middle East Plasma Protein Therapeutics Market Overview
28.2. Middle East Plasma Protein Therapeutics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Plasma Protein Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Plasma Protein Therapeutics Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Plasma Protein Therapeutics Market

29.1. Africa Plasma Protein Therapeutics Market Overview
29.2. Africa Plasma Protein Therapeutics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Plasma Protein Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Plasma Protein Therapeutics Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Plasma Protein Therapeutics Market Competitive Landscape And Company Profiles

30.1. Plasma Protein Therapeutics Market Competitive Landscape
30.2. Plasma Protein Therapeutics Market Company Profiles
- 30.2.1. CSL Behring LLC Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Grifols SA Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. China Biologic Products Holdings Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Takeda Pharmaceutical Company Limited Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Baxter International Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Plasma Protein Therapeutics Market Other Major And Innovative Companies

31.1. Kedrion SpA
31.2. LFB SA
31.3. Emergent BioSolutions Inc.
31.4. Reliance Life Sciences Private Limited
31.5. ADMA Biologics Inc.
31.6. Prothya Biosolutions BV
31.7. Bio Products Laboratory Ltd.
31.8. Biotest AG
31.9. Taibang Biological Group Co Ltd
31.10. Octapharma Plasma Inc.
31.11. New York Blood Center
31.12. Green Cross Corporation
31.13. China National Biotec Group Company Limited
31.14. Kamada Ltd.
31.15. Australian Red Cross Lifeblood

32. Global Plasma Protein Therapeutics Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Plasma Protein Therapeutics Market

34. Recent Developments In The Plasma Protein Therapeutics Market

35. Plasma Protein Therapeutics Market High Potential Countries, Segments and Strategies

35.1 Plasma Protein Therapeutics Market In 2029 - Countries Offering Most New Opportunities
35.2 Plasma Protein Therapeutics Market In 2029 - Segments Offering Most New Opportunities
35.3 Plasma Protein Therapeutics Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer